Golidocitinib With Azacitidine and Chidamide in Patients With Peripheral T-cell Lymphoma.
Clinical trial NCT07081607 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07081607
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2026-07-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.